Spring direct naar de hoofdnavigatie of de inhoud
‘Different parts of patent law seem to a certain extent to conflict. I enjoy exploring the fault lines that such conflicts create. I am mindful of such fault lines when obtaining patents for my clients and strive to exploit them when defending my clients.’
Marlon Blood

Marlon Blood

  • Hightech & Electronics
  • European Patent Attorney
  • Senior Associate

Marlon Blood has worked for many years as IPR manager in Japan for one of the world’s leading mobile communication companies before joining V.O. In this capacity, he acquired substantial experience in contentious IP matters, including the assertion and defense of standard-related mobile communication patents and related litigation.

Continue reading

Marlon has substantial experience in IP acquisition, including pre-filing invention identification and evaluation, drafting, and prosecution. He has considerable experience in acting before the EPO in opposition and appeal proceedings.

Marlon’s current practice and previous experience encompass a broad range of technologies including mobile communication devices and networks, software, lasers, loudspeakers, mail processing systems, capsule-based coffee machines and angling equipment. He read electronic engineering at Reading University, UK.

Working experience

  • Patent Attorney, V.O (2009-present)
  • Patent Attorney, Private practice (2006-2009)
  • IPR Manager in one of the world’s leading telecommunication companies (1995-2005)
  • Patent Attorney, Private practice (1991-1995)

Education

  • BSc in Electronic Engineering, Reading University, UK

Languages

  • English
  • Japanese

Also see these experts

Raimondo Cau

Raimondo Cau

  • European and Dutch Patent Attorney
  • Associate
Hans Bottema

Hans Bottema

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

UPC anti-anti-suit injunctions as interim measures: Munich Local Division in Huawei v Netgear (UPC_CFI_791/2024)

In its Order of 11 December 2024 in UPC_CFI_791/2024 (Munich Local Division), the Unified Patent Court (UPC) granted an ex parte anti-anti-suit/anti-enforcement injunction (AASI/AAEI) to prevent steps in US proceedings that were said to obstruct UPC patent enforcement. The decision is noteworthy for its articulation of the UPC’s jurisdictional basis and the procedural framework for […]Continue reading

R 0016/23: the Enlarged Board confirms the mandatory nature of oral proceedings upon request under Article 116(1) EPC 

In R 0016/23 (Enlarged Board of Appeal, 21 November 2025), the Enlarged Board set aside a Legal Board of Appeal decision which had dismissed an appeal without holding requested oral proceedings. The decision is a clear statement that efficiency and “timely legal certainty” cannot, in themselves, justify restricting the scope of Article 116(1) EPC when […]Continue reading

Medical-device infringement and “standard use”: LD Munich on lege artis use and conditional revocation counterclaims (UPC_CFI_628/2024) 

In its decision on the merits in UPC_CFI_628/2024 (with the related revocation counterclaim UPC_CFI_125/2025), the Munich Local Division of the Unified Patent Court (UPC) addressed two practically relevant issues:Continue reading